We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRT:NASDAQOportun Financial Corporation Analysis

Data as of 2026-09-01 - not real-time

$7.18

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Oportun Financial Corporation is bullish at $7.18, with short-term averages leading the long-term ones. The last 30 days have gained 24.4%. With RSI at 53.0 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $6.00 up to resistance at $8.30.
Valuation screens as undervalued: a P/E of 17.9 sits in line with the sector average of 16.9. Consensus targets land 33.7% above where the shares trade now. Revenue is growing at 9.4% on a 2.6% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 91.6%, a beta of 1.74 and a maximum drawdown of 41.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Oportun Financial OPRT delivered earnings and revenue surprises of +27.SAN CARLOS, Calif., July 22, 2026 GLOBE NEWSWIRE -- Oportun Nasdaq: OPRT , a mission-driven financial services company,...Yahoo Finance26dOportun Financial Corp OPRT Q2 2026 Earnings Call Highlights: Strong Profitability and .

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 5.51
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 17.9 versus sector average of 16.9
  • Trading above the 200-day average of 5.51

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 17.9 versus sector average of 16.9
  • Analyst targets imply +33.7% versus the current price
  • Elevated debt-to-equity of 654

Key Metrics & Analysis

Financial Health

Revenue Growth9.40%
Profit Margin2.62%
P/E Ratio17.9
ROE4.98%
ROA0.62%
Debt/Equity653.91
P/B Ratio0.8
Op. Cash Flow$420.9M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI53.0
Support$6.00
Resistance$8.30
MA 20$7.48
MA 50$6.44
MA 200$5.51
MACDBearish
VolumeDecreasing
Fear & Greed Index93.16

Valuation

Fair Value$66.37
Target Price$9.60
Upside/Downside33.70%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.74
Volatility91.59%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.